MCK
46
-3
LB
41
-11
WU
16
2
V
64
-4
PPL
60
-7
ECL
69
-3
PYPL
45
-2
MCD
63
-4
CA
36
-4
ADP
70
-3
HRL
38
2
IFF
60
-3
KLAC
56
-3
SIG
58
-2
CHRW
48
8
MA
65
-4
HBI
59
-2
MMC
60
-2
HES
59
3
AEP
59
-3
MCK
46
-3
LB
41
-11
WU
16
2
V
64
-4
PPL
60
-7
ECL
69
-3
PYPL
45
-2
MCD
63
-4
CA
36
-4
ADP
70
-3
HRL
38
2
IFF
60
-3
KLAC
56
-3
SIG
58
-2
CHRW
48
8
MA
65
-4
HBI
59
-2
MMC
60
-2
HES
59
3
AEP
59
-3
Financhill
Back

Avidity Biosciences Quote, Financials, Valuation and Earnings

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31

RNA
Avidity Biosciences

Last Price:
45.67
Seasonality Move:
-1.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.

Avidity Biosciences Price Quote

$45.67
+1.03 (+2.31%)
(Updated: September 19, 2024 at 6:45 PM ET)

Avidity Biosciences Key Stats

Sell
31
Avidity Biosciences (RNA) is a Sell
Day range:
$42.19 - $45.25
52-week range:
$4.83 - $48.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
362.55
P/B ratio:
4.28%
Volume:
3.9M
Avg. volume:
1.3M
1-year change:
541.38%
Market cap:
$5.2B
Revenue:
$9.6M
EPS:
$-2.95

How Much Does Avidity Biosciences Make?

Is Avidity Biosciences Growing As A Company?

  • What Is Avidity Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.12%
  • What Is Avidity Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Avidity Biosciences Stock Price Performance

What Is Avidity Biosciences 52-Week High & Low?

Avidity Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Avidity Biosciences?

Is Avidity Biosciences Cash Flow Positive?

  • What Is RNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$155.7M
  • What Is Avidity Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $868.1M
  • What Is Avidity Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$288.1M

Avidity Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    RNA return on invested capital is -34.78%
  • What Is Avidity Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -30.7%
  • What Is RNA Return On Equity?
    ROE is a measure of profitability and is -34.78%

Avidity Biosciences Earnings Date & Stock Price

Avidity Biosciences Competitors

  • Who Are Avidity Biosciences's Competitors?
    Below is a list of companies who compete with Avidity Biosciences or are related in some way:
    • BioCryst Pharmaceuticals Inc (BCRX)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • PepGen Inc (PEPG)
    • Sarepta Therapeutics Inc (SRPT)

Avidity Biosciences Dividend Yield

Avidity Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 17.12%
Revenue: -11.7% -32.13%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 66.80
Upside from Last Price: 49.64%

Major Shareholders

  • How many RNA shares are owned by institutional investors?
    198M RNA shares are owned by institutional investors
  • How many RNA shares are owned by insiders?
    523.4K RNA shares are owned by insiders